Didier Branellec

Title: Didier Branellec: Innovator in Cardiac Gene Therapy

Introduction

Didier Branellec is a notable inventor based in Brie-Comte-Robert, France. He has made significant contributions to the field of cardiac gene therapy, particularly through his innovative research and patenting activities. His work focuses on the development of novel promoter sequences that enhance the expression of transgenes in cardiac muscle cells.

Latest Patents

Branellec holds a patent titled "Sequences upstream of the CARP gene, vectors containing them and uses thereof." This invention relates to novel promoter sequences derived from a portion upstream of the coding sequence of the CARP protein (Cardiac Ankyrin Repeat Protein). These sequences are capable of controlling the level and specificity of transgene expression in vivo within cardiac muscle cells. The patent describes various compositions, constructs, and vectors, along with their applications for transferring and expressing nucleic acids in cardiac muscle cells. Additionally, the promoter sequences can be utilized for generating transgenic animals that serve as models for studying specific cardiac pathologies. He has 1 patent to his name.

Career Highlights

Throughout his career, Didier Branellec has worked with prominent organizations, including Centelion and the University of California. His experience in these institutions has allowed him to collaborate with leading experts in the field of cardiac research and gene therapy.

Collaborations

Branellec has collaborated with notable colleagues such as Patrick Benoit and Bertrand Schwartz. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Didier Branellec is a pioneering inventor whose work in cardiac gene therapy has the potential to impact the treatment of cardiac diseases significantly. His innovative approaches and patented technologies are paving the way for future advancements in the field.